
FIGS BCG MATRIX TEMPLATE RESEARCH
The FIGS BCG Matrix snapshot highlights which product lines are driving growth and which may be consuming cash without return-essential for prioritizing investment and divestment decisions in a competitive apparel market. This preview teases quadrant placements and top-line implications, but the full BCG Matrix delivers quadrant-by-quadrant data, actionable recommendations, and editable Word and Excel files to speed strategic planning. Purchase the complete report for a turnkey tool that shows where to allocate capital, optimize the portfolio, and sharpen competitive focus.
Stars
FIGS' International Market Operations are a Star: Q4 2025 international net revenue jumped 55.1% to $37.7 million, and full-year 2025 international sales rose 27.5% to $103.6 million, now >16% of total revenue, showing clear global scalability.
Non-Scrubwear Lifestyle Portfolio grew 26.4% in Q4 2025 to $47.0M, now 23% of FIGS total net revenue, reflecting the company's shift from uniform supplier to lifestyle brand.
FORMx fabric and outerwear-notably high-pile bombers-and Archtech compression socks drive expansion into the $79B medical apparel market, lifting category momentum and margin diversification.
The FIGS mobile app has become a high-growth engine, helping drive 2.9 million active customers by end-2025 and lifting Average Order Value to $120, a 6.2% YoY gain, via AI-driven personalization and exclusive drops.
Community Hubs (Physical Retail)
FIGS expanded physical footprint in 2025 by opening three new Community Hubs in major U.S. cities, with four more planned for 2026; these hubs act as high-growth brand beacons to drive high-intent traffic and local share.
Capex for these hubs rose to $8.2 million in 2025, reflecting first-to-market scale in premium DTC medical retail and supporting higher conversion and lifetime value.
- 3 hubs opened (2025); 4 planned (2026)
- 2025 capex: $8.2 million
- Purpose: retail + community center; boost local market share
- Strategic: first-mover in premium DTC medical physical retail
Active Customer Acquisition
FIGS reached a record 2.9 million active customers by end-2025, up 9.4%, marking high growth in a crowded apparel/healthcare market.
Net revenue per active customer rose to $216, showing newer cohorts spend more and retain longer.
Keeping Star momentum required heavy marketing-$28.3 million in Q4 2025-underscoring elevated investment to sustain growth.
- 2.9M active customers (2025)
- +9.4% YoY growth
- $216 net revenue per active customer
- $28.3M marketing spend in Q4 2025
FIGS' Stars: international net revenue rose 55.1% in Q4 2025 to $37.7M; full-year international sales 2025 $103.6M (16%+ of revenue); non-scrubwear lifestyle $47.0M Q4 (23% of revenue); active customers 2.9M (+9.4%), AOV $120, net revenue per active customer $216; 2025 capex for hubs $8.2M; Q4 marketing $28.3M.
| Metric | 2025 |
|---|---|
| Intl net revenue Q4 | $37.7M |
| Intl sales FY | $103.6M |
| Non-scrubwear Q4 | $47.0M |
| Active customers | 2.9M |
| AOV | $120 |
| Net rev/active | $216 |
| Hubs capex | $8.2M |
| Q4 marketing | $28.3M |
What is included in the product
Comprehensive BCG Matrix for FIGS: strategic guidance on Stars, Cash Cows, Question Marks, and Dogs with investment, hold, or divest recommendations.
One-page FIGS BCG Matrix placing each business unit in a quadrant for instant portfolio clarity
Cash Cows
Core Scrubwear Styles are FIGS' cash cow, delivering $508.9 million in 2025 and representing over 60% of net revenue, funding growth initiatives.
Seventeen evergreen styles across ten core colors need minimal R&D, producing strong free cash flow for international expansion.
Despite U.S. market maturity, core scrubs grew 14.3% in 2025 and hold nearly 50% share of the premium DTC scrub market.
The proprietary FIONx fabric underpins FIGS' high-margin lineup, driving the bulk of FY2025 revenue and acting as a cash cow; gross margin for the product mix stayed at 66.5% for the full year, with FIONx-related SKU sales representing an estimated 58% of net revenue in 2025.
The U.S. Domestic Market is a cash cow: mature with a 2025 revenue of $527.5 million, supplying the bulk of FIGS' cash flow and supporting a zero-debt balance sheet.
Domestic growth of 11.2% trails international expansion but, with strong logistics and brand awareness, yields high margins and reliable free cash flow.
Management is milking this cash to fund a $50 million share repurchase authorization and sustain operations without debt.
Repeat Customer Base
FIGS' Repeat Customer Base drives steady recurring revenue: existing customers fueled 13.6% revenue growth in 2025, with a historical 10% return rate and 2.9 million users, showing strong retention in a mature market.
Lower marketing spend per sale lets FIGS harvest higher lifetime value (LTV), turning this cash cow into a predictable profit source.
- 2025: 13.6% revenue growth from repeat orders
- Historical return rate: 10%
- User base: 2.9 million
- Lower acquisition spend → higher LTV
Direct-to-Consumer (DTC) Model
FIGS' Direct-to-Consumer model bypasses wholesalers, sustaining a 67% gross margin in mid-2025 and enabling low channel costs.
With $300.8 million cash and $53 million free cash flow in FY2025, the mature DTC engine funds growth without third-party distributor overhead.
- 67% gross margin (mid-2025)
- $300.8M cash balance (2025)
- $53M free cash flow (FY2025)
Core scrubs (FIONx) are FIGS' cash cow: $508.9M revenue (2025), 66.5% gross margin, 58% of net revenue, funding $50M buybacks and $53M FCF; U.S. market $527.5M (2025) with 11.2% growth and 2.9M repeat customers (13.6% repeat-driven revenue).
| Metric | 2025 |
|---|---|
| Core scrubs rev | $508.9M |
| Gross margin | 66.5% |
| FIONx share | 58% |
| US rev | $527.5M |
| FCF | $53M |
What You're Viewing Is Included
FIGS BCG Matrix
The file you're previewing is the exact BCG Matrix report you'll receive after purchase-no watermarks or demo content. Fully formatted and analysis-ready, it's crafted for strategic clarity and market-backed insights. Upon payment you'll get the same editable, printable file directly to your inbox with no surprises or additional revisions needed. Use it immediately in presentations, planning documents, or client deliverables.
Original: $10.00
-65%$10.00
$3.50FIGS BCG MATRIX TEMPLATE RESEARCH
The FIGS BCG Matrix snapshot highlights which product lines are driving growth and which may be consuming cash without return-essential for prioritizing investment and divestment decisions in a competitive apparel market. This preview teases quadrant placements and top-line implications, but the full BCG Matrix delivers quadrant-by-quadrant data, actionable recommendations, and editable Word and Excel files to speed strategic planning. Purchase the complete report for a turnkey tool that shows where to allocate capital, optimize the portfolio, and sharpen competitive focus.
Stars
FIGS' International Market Operations are a Star: Q4 2025 international net revenue jumped 55.1% to $37.7 million, and full-year 2025 international sales rose 27.5% to $103.6 million, now >16% of total revenue, showing clear global scalability.
Non-Scrubwear Lifestyle Portfolio grew 26.4% in Q4 2025 to $47.0M, now 23% of FIGS total net revenue, reflecting the company's shift from uniform supplier to lifestyle brand.
FORMx fabric and outerwear-notably high-pile bombers-and Archtech compression socks drive expansion into the $79B medical apparel market, lifting category momentum and margin diversification.
The FIGS mobile app has become a high-growth engine, helping drive 2.9 million active customers by end-2025 and lifting Average Order Value to $120, a 6.2% YoY gain, via AI-driven personalization and exclusive drops.
Community Hubs (Physical Retail)
FIGS expanded physical footprint in 2025 by opening three new Community Hubs in major U.S. cities, with four more planned for 2026; these hubs act as high-growth brand beacons to drive high-intent traffic and local share.
Capex for these hubs rose to $8.2 million in 2025, reflecting first-to-market scale in premium DTC medical retail and supporting higher conversion and lifetime value.
- 3 hubs opened (2025); 4 planned (2026)
- 2025 capex: $8.2 million
- Purpose: retail + community center; boost local market share
- Strategic: first-mover in premium DTC medical physical retail
Active Customer Acquisition
FIGS reached a record 2.9 million active customers by end-2025, up 9.4%, marking high growth in a crowded apparel/healthcare market.
Net revenue per active customer rose to $216, showing newer cohorts spend more and retain longer.
Keeping Star momentum required heavy marketing-$28.3 million in Q4 2025-underscoring elevated investment to sustain growth.
- 2.9M active customers (2025)
- +9.4% YoY growth
- $216 net revenue per active customer
- $28.3M marketing spend in Q4 2025
FIGS' Stars: international net revenue rose 55.1% in Q4 2025 to $37.7M; full-year international sales 2025 $103.6M (16%+ of revenue); non-scrubwear lifestyle $47.0M Q4 (23% of revenue); active customers 2.9M (+9.4%), AOV $120, net revenue per active customer $216; 2025 capex for hubs $8.2M; Q4 marketing $28.3M.
| Metric | 2025 |
|---|---|
| Intl net revenue Q4 | $37.7M |
| Intl sales FY | $103.6M |
| Non-scrubwear Q4 | $47.0M |
| Active customers | 2.9M |
| AOV | $120 |
| Net rev/active | $216 |
| Hubs capex | $8.2M |
| Q4 marketing | $28.3M |
What is included in the product
Comprehensive BCG Matrix for FIGS: strategic guidance on Stars, Cash Cows, Question Marks, and Dogs with investment, hold, or divest recommendations.
One-page FIGS BCG Matrix placing each business unit in a quadrant for instant portfolio clarity
Cash Cows
Core Scrubwear Styles are FIGS' cash cow, delivering $508.9 million in 2025 and representing over 60% of net revenue, funding growth initiatives.
Seventeen evergreen styles across ten core colors need minimal R&D, producing strong free cash flow for international expansion.
Despite U.S. market maturity, core scrubs grew 14.3% in 2025 and hold nearly 50% share of the premium DTC scrub market.
The proprietary FIONx fabric underpins FIGS' high-margin lineup, driving the bulk of FY2025 revenue and acting as a cash cow; gross margin for the product mix stayed at 66.5% for the full year, with FIONx-related SKU sales representing an estimated 58% of net revenue in 2025.
The U.S. Domestic Market is a cash cow: mature with a 2025 revenue of $527.5 million, supplying the bulk of FIGS' cash flow and supporting a zero-debt balance sheet.
Domestic growth of 11.2% trails international expansion but, with strong logistics and brand awareness, yields high margins and reliable free cash flow.
Management is milking this cash to fund a $50 million share repurchase authorization and sustain operations without debt.
Repeat Customer Base
FIGS' Repeat Customer Base drives steady recurring revenue: existing customers fueled 13.6% revenue growth in 2025, with a historical 10% return rate and 2.9 million users, showing strong retention in a mature market.
Lower marketing spend per sale lets FIGS harvest higher lifetime value (LTV), turning this cash cow into a predictable profit source.
- 2025: 13.6% revenue growth from repeat orders
- Historical return rate: 10%
- User base: 2.9 million
- Lower acquisition spend → higher LTV
Direct-to-Consumer (DTC) Model
FIGS' Direct-to-Consumer model bypasses wholesalers, sustaining a 67% gross margin in mid-2025 and enabling low channel costs.
With $300.8 million cash and $53 million free cash flow in FY2025, the mature DTC engine funds growth without third-party distributor overhead.
- 67% gross margin (mid-2025)
- $300.8M cash balance (2025)
- $53M free cash flow (FY2025)
Core scrubs (FIONx) are FIGS' cash cow: $508.9M revenue (2025), 66.5% gross margin, 58% of net revenue, funding $50M buybacks and $53M FCF; U.S. market $527.5M (2025) with 11.2% growth and 2.9M repeat customers (13.6% repeat-driven revenue).
| Metric | 2025 |
|---|---|
| Core scrubs rev | $508.9M |
| Gross margin | 66.5% |
| FIONx share | 58% |
| US rev | $527.5M |
| FCF | $53M |
What You're Viewing Is Included
FIGS BCG Matrix
The file you're previewing is the exact BCG Matrix report you'll receive after purchase-no watermarks or demo content. Fully formatted and analysis-ready, it's crafted for strategic clarity and market-backed insights. Upon payment you'll get the same editable, printable file directly to your inbox with no surprises or additional revisions needed. Use it immediately in presentations, planning documents, or client deliverables.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
The FIGS BCG Matrix snapshot highlights which product lines are driving growth and which may be consuming cash without return-essential for prioritizing investment and divestment decisions in a competitive apparel market. This preview teases quadrant placements and top-line implications, but the full BCG Matrix delivers quadrant-by-quadrant data, actionable recommendations, and editable Word and Excel files to speed strategic planning. Purchase the complete report for a turnkey tool that shows where to allocate capital, optimize the portfolio, and sharpen competitive focus.
Stars
FIGS' International Market Operations are a Star: Q4 2025 international net revenue jumped 55.1% to $37.7 million, and full-year 2025 international sales rose 27.5% to $103.6 million, now >16% of total revenue, showing clear global scalability.
Non-Scrubwear Lifestyle Portfolio grew 26.4% in Q4 2025 to $47.0M, now 23% of FIGS total net revenue, reflecting the company's shift from uniform supplier to lifestyle brand.
FORMx fabric and outerwear-notably high-pile bombers-and Archtech compression socks drive expansion into the $79B medical apparel market, lifting category momentum and margin diversification.
The FIGS mobile app has become a high-growth engine, helping drive 2.9 million active customers by end-2025 and lifting Average Order Value to $120, a 6.2% YoY gain, via AI-driven personalization and exclusive drops.
Community Hubs (Physical Retail)
FIGS expanded physical footprint in 2025 by opening three new Community Hubs in major U.S. cities, with four more planned for 2026; these hubs act as high-growth brand beacons to drive high-intent traffic and local share.
Capex for these hubs rose to $8.2 million in 2025, reflecting first-to-market scale in premium DTC medical retail and supporting higher conversion and lifetime value.
- 3 hubs opened (2025); 4 planned (2026)
- 2025 capex: $8.2 million
- Purpose: retail + community center; boost local market share
- Strategic: first-mover in premium DTC medical physical retail
Active Customer Acquisition
FIGS reached a record 2.9 million active customers by end-2025, up 9.4%, marking high growth in a crowded apparel/healthcare market.
Net revenue per active customer rose to $216, showing newer cohorts spend more and retain longer.
Keeping Star momentum required heavy marketing-$28.3 million in Q4 2025-underscoring elevated investment to sustain growth.
- 2.9M active customers (2025)
- +9.4% YoY growth
- $216 net revenue per active customer
- $28.3M marketing spend in Q4 2025
FIGS' Stars: international net revenue rose 55.1% in Q4 2025 to $37.7M; full-year international sales 2025 $103.6M (16%+ of revenue); non-scrubwear lifestyle $47.0M Q4 (23% of revenue); active customers 2.9M (+9.4%), AOV $120, net revenue per active customer $216; 2025 capex for hubs $8.2M; Q4 marketing $28.3M.
| Metric | 2025 |
|---|---|
| Intl net revenue Q4 | $37.7M |
| Intl sales FY | $103.6M |
| Non-scrubwear Q4 | $47.0M |
| Active customers | 2.9M |
| AOV | $120 |
| Net rev/active | $216 |
| Hubs capex | $8.2M |
| Q4 marketing | $28.3M |
What is included in the product
Comprehensive BCG Matrix for FIGS: strategic guidance on Stars, Cash Cows, Question Marks, and Dogs with investment, hold, or divest recommendations.
One-page FIGS BCG Matrix placing each business unit in a quadrant for instant portfolio clarity
Cash Cows
Core Scrubwear Styles are FIGS' cash cow, delivering $508.9 million in 2025 and representing over 60% of net revenue, funding growth initiatives.
Seventeen evergreen styles across ten core colors need minimal R&D, producing strong free cash flow for international expansion.
Despite U.S. market maturity, core scrubs grew 14.3% in 2025 and hold nearly 50% share of the premium DTC scrub market.
The proprietary FIONx fabric underpins FIGS' high-margin lineup, driving the bulk of FY2025 revenue and acting as a cash cow; gross margin for the product mix stayed at 66.5% for the full year, with FIONx-related SKU sales representing an estimated 58% of net revenue in 2025.
The U.S. Domestic Market is a cash cow: mature with a 2025 revenue of $527.5 million, supplying the bulk of FIGS' cash flow and supporting a zero-debt balance sheet.
Domestic growth of 11.2% trails international expansion but, with strong logistics and brand awareness, yields high margins and reliable free cash flow.
Management is milking this cash to fund a $50 million share repurchase authorization and sustain operations without debt.
Repeat Customer Base
FIGS' Repeat Customer Base drives steady recurring revenue: existing customers fueled 13.6% revenue growth in 2025, with a historical 10% return rate and 2.9 million users, showing strong retention in a mature market.
Lower marketing spend per sale lets FIGS harvest higher lifetime value (LTV), turning this cash cow into a predictable profit source.
- 2025: 13.6% revenue growth from repeat orders
- Historical return rate: 10%
- User base: 2.9 million
- Lower acquisition spend → higher LTV
Direct-to-Consumer (DTC) Model
FIGS' Direct-to-Consumer model bypasses wholesalers, sustaining a 67% gross margin in mid-2025 and enabling low channel costs.
With $300.8 million cash and $53 million free cash flow in FY2025, the mature DTC engine funds growth without third-party distributor overhead.
- 67% gross margin (mid-2025)
- $300.8M cash balance (2025)
- $53M free cash flow (FY2025)
Core scrubs (FIONx) are FIGS' cash cow: $508.9M revenue (2025), 66.5% gross margin, 58% of net revenue, funding $50M buybacks and $53M FCF; U.S. market $527.5M (2025) with 11.2% growth and 2.9M repeat customers (13.6% repeat-driven revenue).
| Metric | 2025 |
|---|---|
| Core scrubs rev | $508.9M |
| Gross margin | 66.5% |
| FIONx share | 58% |
| US rev | $527.5M |
| FCF | $53M |
What You're Viewing Is Included
FIGS BCG Matrix
The file you're previewing is the exact BCG Matrix report you'll receive after purchase-no watermarks or demo content. Fully formatted and analysis-ready, it's crafted for strategic clarity and market-backed insights. Upon payment you'll get the same editable, printable file directly to your inbox with no surprises or additional revisions needed. Use it immediately in presentations, planning documents, or client deliverables.











